The Globe has a story about a trio of Cambridge, Mass.firms moving fast to develop and commercialize drugs and biotech products using CRISPR, the gene-editing tool (including one company called CRISPR, which gets the bulk of the coverage because it is parterning with drug giant Bayer).
CRISPR was the topic of a Science Cafe NH discussion earlier this year, because we at Science Cafe are always on top of what’s important. Well, sometimes on top of it.
.
Return to the Concord Monitor